Navigation Links
Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
Date:11/27/2012

ALISO VIEJO, Calif., Nov. 27, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced preliminary results for the quarter ended September 30, 2012.

Financial Update

Based on preliminary results for the fourth fiscal quarter ended September 30, 2012, Avanir estimates:

  • Gross revenue for NUEDEXTA® of $15.4 million, representing an increase of approximately 26% over the prior quarter
  • Total operating expenses, excluding cost of product sales and non-cash items such as share-based compensation, depreciation and amortization, between $21.7 to $22.2 million
  • More than 11,000 total prescriptions for the month of October 2012
  • Cash, cash equivalents and investments in securities totaling approximately $72.1 million, including cash and cash equivalents of approximately $69.8 million and restricted investments in securities of approximately $2.3 million

"We are delighted with the progress that we continue to make on a quarterly basis with our commercial efforts around NUEDEXTA," said Keith Katkin, president and CEO of Avanir. "Additionally, the team continues to be cost conscious and I anticipate that we will report total year operating expenses, excluding cost of product sales and non-cash items such as share-based compensation, depreciation and amortization  at the lower end of our $94 to $96 million guidance."

Clinical Update

The company also announced that it has initiated the first-in-human Phase I clinical trial of AVP-786 (formerly known as deuterated dextromethorphan). The trial is designed to assess the single and multiple dose pharmacokinetics, safety and tolerability of AVP-786 administered to healthy subjects.

Approximately 40 subjects will be enrolled in this randomized crossover study to compare multiple dose levels of AVP-
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Avanir Pharmaceuticals To Present At 24th Annual Piper Jaffray Healthcare Conference
2. Avanir Pharmaceuticals Achieves Commercial Milestones & Provides Clinical Updates
3. Avanir Pharmaceuticals To Present At UBS Global Life Sciences Conference
4. Avanir Pharmaceuticals Announces Publication Of PBA Burden Of Illness Study
5. Avanir Pharmaceuticals Announces Enrollment Of First Patient In Study Of AVP-923 For The Treatment Of Agitation In Patients With Alzheimers Disease
6. Avanir Pharmaceuticals To Present At Two Investor Conferences In August
7. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Third Quarter Financial Results And Conference Call
8. Avanir Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
9. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call
10. Avanir Pharmaceuticals To Present at Three Conferences In May
11. Unigene and Tarix Pharmaceuticals Enter Definitive Licensing Agreement for "Peptelligence-Engineered" TXA127
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... , Dec. 22, 2014 Research and ... the addition of the "Investment Analysis of ... to their offering. ... in the US medical device sector identifies the ... and venture capital investments, and mergers and acquisitions. ...
(Date:12/22/2014)... Cyberonics, Inc. (NASDAQ: CYBX ), a ... of epilepsy, today announced it will participate in the 33 ... 14, 2015, in San Francisco . ... Officer, will speak at 11:00 AM Pacific Time.  A live ... on the Investor Relations link on the Cyberonics home page ...
(Date:12/22/2014)... /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII ... and commercializing innovative therapies addressing major unmet medical ... open letter to shareholders from President & CEO, ... Dear RXi Shareholders, In the ... posted on certain social media sites seem to ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6
... 9, 2012  CareFusion Corporation (NYSE: CFN ) today ... this afternoon by Chairman and CEO Kieran T. Gallahue at ... said it expects revenue for its second fiscal quarter, ended ... and operating income to be $141 million to $146 million. ...
... Jan. 9, 2012 Ampio Pharmaceuticals, Inc. (NASDAQ: ... that discovers and develops new uses for previously approved ... Wingerter would be granted a compassionate leave from all ... to serious illnesses afflicting his closest family members.  The ...
Cached Medicine Technology:CareFusion Announces Preliminary Second Quarter Results 2CareFusion Announces Preliminary Second Quarter Results 3CareFusion Announces Preliminary Second Quarter Results 4CareFusion Announces Preliminary Second Quarter Results 5CareFusion Announces Preliminary Second Quarter Results 6Executive Changes at Ampio 2Executive Changes at Ampio 3
(Date:12/24/2014)... Dr. Ronald Receveur, a New ... dental implants in a day, has written ... overusing teeth-whitening treatments. , In his blog published ... Receveur writes that overusing teeth-whitening treatments can lead to ... enamel. , “Because teeth-whitening treatments are available ...
(Date:12/24/2014)... News) -- Longer and colder body cooling does not reduce ... from a lack of oxygen, a new study finds. ... condition -- called hypoxic ischemic encephalopathy -- can be reduced ... Fahrenheit) for 72 hours, experts say. Research has shown ... so this study examined if the same would be true ...
(Date:12/22/2014)... December 22, 2014 B. E. Smith, ... healthcare providers, has been retained to lead a national ... Medical Center in Oceanside, Calif. The top ... E. Smith has recently placed more than 900 healthcare ... a community owned, 397-bed, Gold Seal-approved, full-service acute-care hospital ...
(Date:12/22/2014)... 22, 2014 Sagacious Consultants, the premier ... subscription option to their ad hoc report writing service ... Customers can sign up for an annual subscription and ... month at a deeply discounted hourly rate. , ... has a progressively discounted rate. Subscription hours are contracted ...
(Date:12/22/2014)... News) -- U.S. and state health officials are investigating ... killed at least four people and sickened 28 others ... commercially produced, prepackaged caramel apples until more information becomes ... said in a news release. As of Dec. ... with the outbreak strains of the bacteria Listeria ...
Breaking Medicine News(10 mins):Health News:New Albany Dentist Weighs In On New Trend of Overbleaching Teeth 2Health News:New Albany Dentist Weighs In On New Trend of Overbleaching Teeth 3Health News:Greater Cooling of Oxygen-Deprived Infants Fails to Improve Survival 2Health News:Tri-City Medical Center Retains B. E. Smith to Recruit New Chief Compliance Officer 2Health News:Tri-City Medical Center Retains B. E. Smith to Recruit New Chief Compliance Officer 3Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 3Health News:CDC Warns of Listeria Danger From Caramel Apples 2
... Education Secretary,Gerald L. Zahorchak today issued the ... approving House Bill 1841, legislation to create,a statewide ... House Education Committee took a major step today ... care for educators,and cut down on teacher strikes," ...
... million Americans have survived a heart attack or have ... one cause of death in the United States. In ... diet and exercise, are known to reduce the risk ... proportion of heart attack survivors do not follow their ...
... Helps Drive Growth in ... Interactive Patient Care, ... of Interactive Patient Care (IPC) solutions, today announced that,Irwin Studen ... chief financial officer. With extensive experience in the,healthcare and technology ...
... back vivid, 30-year-old memories for patient, researchers say , , ... (DBS) may help improve memory, suggests a Canadian study ... prompted detailed memories in a patient. , DBS ... -- is used to treat Parkinson,s disease and other ...
... doctors as a hormone that boosts red-blood-cell production. Now, ... ophthalmologist at Children,s Hospital Boston, shows it also keeps blood ... not only add a new function to the hormone, but ... to patients with diseases affected by abnormal blood-vessel growth, such ...
... Pharmaceutical,Laboratories, Ltd. (Amex: CPD ) announced today ... mg (Pantoprazole Sodium,DR), which is AB-rated to Wyeth,s ... Ltd. (Sun Pharma). Sun Pharma recently received,approval from ... its Abbreviated,New Drug Application (ANDA) for generic Protonix(R), ...
Cached Medicine News:Health News:UMass Medical School study finds patients diagnosed with coronary heart disease continue poor diets 2Health News:UMass Medical School study finds patients diagnosed with coronary heart disease continue poor diets 3Health News:Irwin Studen Joins GetWellNetwork as Senior Vice President and Chief Financial Officer 2Health News:Irwin Studen Joins GetWellNetwork as Senior Vice President and Chief Financial Officer 3Health News:Deep Brain Stimulation May Improve Recall 2Health News:Anemia treatment may be a double-edged sword 2Health News:Anemia treatment may be a double-edged sword 3Health News:Caraco Pharmaceutical Laboratories Ltd. to Market Generic Protonix(R) 2Health News:Caraco Pharmaceutical Laboratories Ltd. to Market Generic Protonix(R) 3
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With polished ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTP/1Q-PAL chairs are recommended for ... clean room, static control, health care ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTP/1Q-PAL chairs are recommended for ... clean room, static control, health care ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
Medicine Products: